Shares of Biogen Inc. BIIB, -0.05% were down 0.2% in premarket trading on Thursday after the company said it plans to build a gene therapy manufacturing site at its campus in Research Triangle Park region in North Carolina.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,